Q3 2024 |
31 |
$48.8M |
+$12.4M |
-$7.55M |
+$4.86M |
BACPRL, NEEPRS, APOPRA
|
13F-HR |
10/11/2024, 10:01 AM |
Q2 2024 |
27 |
$43.3M |
+$13.2M |
-$1.86M |
+$11.4M |
BACPRL, NEEPRR, APOPRA
|
13F-HR |
7/5/2024, 09:59 AM |
Q1 2024 |
25 |
$6.68M |
+$1.39M |
-$3.14M |
-$1.75M |
BACPRL, NEEPRR, LUV, XOM
|
13F-HR |
5/8/2024, 09:42 AM |
Q4 2023 |
26 |
$23.2M |
+$6.34M |
-$1.3M |
+$5.04M |
BACPRL, BKNG, LUV, NTR, XOM
|
13F-HR |
1/29/2024, 09:15 AM |
Q3 2023 |
25 |
$7.43M |
+$854K |
-$161K |
+$692K |
BACPRL
|
Restatement |
10/31/2023, 11:34 AM |
Q2 2023 |
28 |
$3.95M |
+$8.57K |
-$2.85K |
+$5.72K |
BACPRL
|
13F-HR |
9/14/2023, 12:43 PM |
Q1 2023 |
19 |
$3.93M |
+$3.14K |
-$108K |
-$105K |
BACPRL
|
Restatement |
5/16/2023, 12:27 PM |
Q4 2022 |
23 |
$4M |
+$3.89M |
-$19.1M |
-$15.2M |
BACPRL, XOM
|
13F-HR |
2/13/2023, 09:52 AM |
Q2 2022 |
18 |
$19.2M |
+$3.43M |
-$9.79M |
-$6.36M |
PBR, MSFT, NTR, XOM
|
13F-HR |
8/3/2022, 08:42 AM |
Q1 2022 |
25 |
$29.9M |
+$20.2M |
-$5.81M |
+$14.4M |
PBR, MSFT, V, NEEPRO, BKR
|
13F-HR |
5/10/2022, 01:29 PM |
Q3 2021 |
21 |
$15.6M |
+$5.08M |
-$6.82M |
-$1.74M |
MSFT, SWT, AMZN, NEEPRO, BKR
|
13F-HR |
11/9/2021, 11:55 AM |
Q1 2021 |
20 |
$17.7M |
+$2.72M |
-$6.24M |
-$3.52M |
MSFT, AMZN, V, BKR, SWT
|
13F-HR |
5/10/2021, 01:11 PM |
Q4 2020 |
25 |
$20.8M |
+$4.88M |
-$11.7M |
-$6.79M |
MSFT, AMZN, NEEPRO, V, BKR
|
13F-HR |
2/4/2021, 12:54 PM |
Q3 2020 |
27 |
$26M |
+$10.4M |
-$10.4M |
+$3.25K |
BACPRL, MSFT, AMZN, NOW, NEEPRO
|
13F-HR |
10/28/2020, 12:39 PM |
Q2 2020 |
30 |
$25.3M |
+$12.2M |
-$12.4M |
-$265K |
BACPRL, MSFT
|
13F-HR |
7/27/2020, 11:10 AM |
Q1 2020 |
30 |
$24M |
+$6.56M |
-$36.9M |
-$30.3M |
BACPRL
|
13F-HR |
5/7/2020, 01:26 PM |
Q4 2019 |
27 |
$58.2M |
+$14.8M |
-$7.22M |
+$7.56M |
ARCH, BACPRL, WFCPRL
|
13F-HR |
2/13/2020, 10:02 AM |
Q3 2019 |
25 |
$51.1M |
+$12.7M |
-$9.08M |
+$3.59M |
ARCH, BACPRL, WFCPRL
|
13F-HR |
11/12/2019, 09:35 AM |
Q2 2019 |
16 |
$56.4M |
+$4.96M |
-$3.67M |
+$1.29M |
ARCH, BACPRL, WFCPRL
|
13F-HR |
7/9/2019, 11:20 AM |
Q1 2019 |
18 |
$53.5M |
+$3.94M |
-$3.42M |
+$513K |
ARCH, BACPRL, WFCPRL
|
13F-HR |
4/29/2019, 10:35 AM |
Q4 2018 |
14 |
$48.7M |
+$48.7M |
-$45K |
+$48.6M |
ARCH, BACPRL, CCIPRA, WFCPRL
|
13F-HR |
2/11/2019, 10:50 AM |
Q3 2018 |
1 |
$45K |
$0 |
-$8.44K |
-$8.44K |
ACIIQ
|
Restatement |
10/30/2018, 09:36 AM |
Q2 2018 |
1 |
$46.9K |
$0 |
-$6 |
-$6 |
ACIIQ
|
13F-HR |
7/10/2018, 09:42 AM |
Q1 2018 |
1 |
$54.9K |
$0 |
-$1.7M |
-$1.7M |
ACIIQ
|
13F-HR |
5/14/2018, 11:15 AM |
Q4 2017 |
12 |
$57.8M |
+$2.07M |
-$1.06M |
+$1.02M |
ACIIQ, BNDX, EFA, CWB, DFE
|
13F-HR |
2/12/2018, 12:54 PM |
Q3 2017 |
12 |
$44.3M |
+$280K |
-$2.76M |
-$2.48M |
ACIIQ, RYAAY, BNDX, EFA, EMB
|
13F-HR |
11/13/2017, 10:08 AM |
Q2 2017 |
14 |
$2.61M |
+$1.64M |
-$40.9M |
-$39.3M |
RYAAY, EMB, EEM, VNQ, DFE
|
13F-HR |
8/11/2017, 07:34 AM |
Q1 2017 |
3 |
$41.7M |
+$41.7M |
-$129M |
-$87.8M |
LBTYA, RYAAY, ACIIQ
|
13F-HR |
5/12/2017, 01:01 PM |
Q4 2016 |
4 |
$129M |
+$126M |
-$141M |
-$15.1M |
LBTYA, ARCH, LILA, CRTO
|
13F-HR |
2/9/2017, 11:28 AM |
Q3 2016 |
2 |
$142M |
$0 |
-$23.8M |
-$23.8M |
CRTO
|
13F-HR |
11/14/2016, 09:34 AM |
Q2 2016 |
2 |
$158M |
+$33M |
-$584M |
-$551M |
CRTO
|
13F-HR |
7/28/2016, 08:51 AM |
Q1 2016 |
7 |
$775M |
$0 |
-$294M |
-$294M |
MU, WDC, PXD, CXO, EOG
|
13F-HR |
5/11/2016, 09:20 AM |
Q4 2015 |
7 |
$1.21B |
+$208M |
-$470M |
-$262M |
WDC, MU, EOG, CXO, PXD
|
Restatement |
2/16/2016, 08:43 AM |
Q3 2015 |
3 |
$1.75B |
+$207M |
-$2.5M |
+$204M |
WDC, MU
|
13F-HR |
10/16/2015, 08:25 AM |
Q2 2015 |
4 |
$1.7B |
$0 |
-$154M |
-$154M |
WDC, MU, PBI
|
13F-HR |
7/6/2015, 07:43 AM |
Q1 2015 |
5 |
$2.12B |
+$142M |
-$277M |
-$135M |
WDC, MU, BTU, PBI
|
13F-HR |
4/16/2015, 08:31 AM |
Q4 2014 |
6 |
$2.76B |
$0 |
$0 |
|
WDC, MU, AAPL, BTU, PBI
|
13F-HR |
1/7/2015, 11:51 AM |